VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
NMRA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
NMRANeumora Therapeutics, Inc. Common Stock
$0.37$68M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksNMRAQuarterly Cash Flow

Neumora Therapeutics, Inc. Common Stock (NMRA) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Neumora Therapeutics, Inc. Common Stock (NMRA) quarterly cash flow statement — complete operating, investing & financing history

Income StatementBalance SheetCash FlowRatios

NMRA Cash Flow Statement

Quarterly statement

NMRA Cash Flow Statement

Neumora Therapeutics, Inc. Common Stock (NMRA) cash flow statement — 6-year operating, investing & financing cash flows

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q2'22Q1'22Q4'21Q3'21
Cash from Operations-33.44M-39.53M-46.4M-47.95M-46.63M-52.4M-59.45M-50.34M-33.48M-56.16M-42.95M-51.44M-47.77M-31.02M-33.04M-30.37M-26.58M-32.19M-29.35M-17.26M
Operating CF Margin %-208993.75%-------------------
Operating CF Growth %28.29%24.57%21.94%4.74%-39.27%6.68%-38.4%2.14%29.91%-81.03%-30.01%-69.41%--16.71%-2.66%-3.45%---77.76%-
Net Income-34.44M-43.08M-53.46M-59.45M-56.76M-52.73M-67.99M-58.82M-72.55M-58.7M-53.72M-108.73M-53.03M-38.54M-35.63M-28.15M-30.37M-43.04M-26.97M-178.03M
Depreciation & Amortization3K7K8K9K23K19K157K157K156K160K158K166K173K991K158K147K479K147K131K150K
Stock-Based Compensation6.14M7.18M7.41M7.41M5.98M7.17M9.32M9.9M9.95M12.77M7.37M6.05M6.45M02.19M2.79M01.65M1.22M1.19M
Deferred Taxes00000000000000000000
Other Non-Cash Items-37.88M28.33M406K870K-364K747K-412K-225K-472K-1.35M-356K64.18M-177K1.43M-6.09M18K1.58M13.11M750K157.18M
Working Capital Changes32.73M-31.97M-765K3.21M4.48M-7.6M-525K-1.36M29.43M-9.03M3.59M-13.11M-1.19M5.1M6.32M-5.18M1.73M-4.06M-4.48M2.25M
Change in Receivables00000000000000000000
Change in Inventory00000000000000000000
Change in Payables-2.19M-909K1.68M2.83M-96K-408K-2.25M-2.9M5.03M-410K1.16M-1.91M306K7.04M0-3.11M1.27M-13K-869K-234K
Cash from Investing-71K071K42.65M51.32M30.4M44.16M-98.8M156.99M21.25M-150M13.68M23.82M24.08M2.82M-8.03M-91.07M-85.61M-188K-547K
Capital Expenditures00016K-16K00000-775K-4.63M-37K0-36K-23K-182K-176K-188K-217K
CapEx % of Revenue--------------------
Acquisitions-71K071K087K84K00000000000000
Investments--------------------
Other Investing000184K0896K000000002.85M00-13M0-330K
Cash from Financing2.33M9.29M10.88M58.77M-136K18.46M015.57M1.53M2.65M1.84M-481K232.02M292K101K26.83M2.08M-351K-358K291.99M
Debt Issued (Net)00038.9M-136K18.4M00000000000000
Equity Issued (Net)09.73M10.88M216K059K013.69M1.76M2.65M1.84M-481K0292K-491K24.97M2.08M0-63K0
Dividends Paid00000000000000000000
Share Repurchases00000000000000-491K00000
Other Financing2.33M-445K019.65M0001.88M-225K000232.02M0592K1.86M0-351K-295K291.99M
Net Change in Cash-31.18M-30.24M-35.46M53.46M4.55M-3.55M-15.29M-133.57M125.04M-32.25M-191.11M-38.25M208.07M-6.65M-30.12M-11.56M-291.23M-118.14M-29.9M274.18M
Free Cash Flow-33.44M-39.53M-46.4M-47.94M-46.65M-52.4M-59.45M-50.34M-33.48M-56.16M-42.95M-51.49M-47.81M-31.02M-33.08M-30.39M-26.76M-32.36M-29.54M-17.47M
FCF Margin %-208993.75%-------------------
FCF Growth %28.32%24.57%21.94%4.77%-39.32%6.68%-38.4%2.23%29.97%-81.03%-29.86%-69.42%--15.92%-2.21%-2.87%---65.84%-
FCF per Share-0.18-0.21-0.26-0.29-0.29-0.32-0.37-0.31-0.21-0.35-0.27-0.32-0.31-0.20-0.22-0.20-0.18-0.21-0.19-0.11
FCF Conversion (FCF/Net Income)0.97x0.92x0.87x0.81x0.82x0.99x0.87x0.86x0.46x0.96x0.80x0.47x0.90x0.80x0.93x1.08x0.88x0.75x1.09x0.10x
Interest Paid000833K0000000000000000
Taxes Paid000323K0000000000000000